Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction

Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3102-3103. doi: 10.1007/s12070-021-02818-z. Epub 2021 Aug 22.

Luigi Angelo Vaira^{1

2}, Jerome R Lechien^{3

4}, Stefano Dore⁵, Riccardo Boccaletti⁶, Sven Saussez^{3

4}, Giacomo De Riu^{1

2}

¹ Maxillofacial Surgery Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Viale San Pietro 10, 07100 Sassari, Italy.
² Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
³ COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Oto-Rhino-Laryngological Societies (YO-IFOS), Paris, France.
⁴ Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
⁵ Ophthalmology Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
⁶ Neurosurgery Operative Unit, University Hospital of Sassari, Sassari, Italy.

No abstract available

Keywords: Anosmia; Coronavirus; Corticosteroids; Covid-19; SARS-CoV-2; Smell disorders; Therapy.